CD4 and neoplasm: Taken together, the standard FACS characterization of T cells in figure 2, with the Tocky data from figure 3, led us to conclude that tumor-reactive Tocky signal positive PAt Treg, although reduced in number by HSV/BRAFi treatment, become activated and are preferentially engaged with antigens, relative to their effector, conventional CD4 cell counterparts.